SCHEMBL23200420

SCHEMBL23200420

C=C(C(=O)OC(C)CC)C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2776589 0.85 TSHR (0.31) TSHR
SCHEMBL5011169 0.82 FAAH (0.40)
SCHEMBL3451003 0.81 LMNA (0.38)
SCHEMBL21723488 0.81 FAAH (0.45)
SCHEMBL27757788 0.80 FAAH (0.48)
SCHEMBL13515122 0.80
SCHEMBL27757790 0.80 FAAH (0.48)
SCHEMBL27737028 0.80 FAAH (0.48)
SCHEMBL1958622 0.79 TSHR (0.39) TSHR
SCHEMBL13387364 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711518-A1 COATED FIBERS AND MOLDED BODY USING SAME Kuraray Co., Ltd. (JP) 2026-03-18 EP disclosed
US-12460111-B2 Reinforcing fibers and production method therefor, and molded article using same KURARAY CO., LTD. (JP) 2025-11-04 US disclosed
WO-2024237206-A1 COATED FIBERS AND MOLDED BODY USING SAME 株式会社クラレ 2024-11-21 WO disclosed
US-11884788-B2 Reinforcing fiber, method for manufacturing same, and molded body using same KURARAY CO., LTD. (JP) 2024-01-30 US disclosed
US-20230303808-A1 EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME KURARAY CO., LTD. (JP) 2023-09-28 US disclosed
CN-112585113-B Process for distillative purification of fluorine-containing polymerizable monomers 中央硝子株式会社 2023-08-22 CN disclosed
EP-4206233-A1 EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME Kuraray Co., Ltd. (JP) 2023-07-05 EP disclosed
US-11597696-B2 Method for purifying polymerizable fluoromonomer by distillation CENTRAL GLASS COMPANY, LIMITED (JP) 2023-03-07 US disclosed
US-20220049062-A1 REINFORCING FIBER, METHOD FOR MANUFACTURING SAME, AND MOLDED BODY USING SAME KURARAY CO., LTD. (JP) 2022-02-17 US disclosed
EP-3933101-A1 REINFORCING FIBER, METHOD FOR MANUFACTURING SAME, AND MOLDED BODY USING SAME Kuraray Co., Ltd. (JP) 2022-01-05 EP disclosed
US-20210317065-A1 Method for Purifying Polymerizable Fluoromonomer by Distillation CENTRAL GLASS COMPANY, LIMITED (JP) 2021-10-14 US disclosed
CN-113454282-A Reinforcing fiber, method for producing same, and molded body using same 株式会社可乐丽 2021-09-28 CN disclosed
US-20210222036-A1 REINFORCING FIBERS AND PRODUCTION METHOD THEREFOR, AND MOLDED ARTICLE USING SAME KURARAY CO., LTD. (JP) 2021-07-22 US disclosed
EP-3805451-A1 REINFORCING FIBERS AND PRODUCTION METHOD THEREFOR, AND MOLDED ARTICLE USING SAME Kuraray Co., Ltd. (JP) 2021-04-14 EP disclosed
CN-112585113-A Method for purifying fluorine-containing polymerizable monomer by distillation 中央硝子株式会社 2021-03-30 CN disclosed
CN-112204192-A Reinforcing fiber, method for producing same, and molded body using same 株式会社可乐丽 2021-01-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317065-A1 Method for Purifying Polymerizable Fluoromonomer by Distillation AFF1, AFF4, AFF2 TP53 3336/4885RXFP1 2933/4885TSHR 3387/4885
US-11597696-B2 Method for purifying polymerizable fluoromonomer by distillation AFF1, AFF4, AFF2 TP53 3336/4885RXFP1 2933/4885TSHR 3387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.